These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11288964

  • 1. Rescue use of abciximab improves regional left ventricular function after early incomplete reperfusion in acute myocardial infarction.
    Cho GY, Lee CW, Hong MK, Kang DH, Song JK, Kim JJ, Park SW, Park SJ.
    Clin Cardiol; 2001 Mar; 24(3):197-201. PubMed ID: 11288964
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Abciximab improves 6-month clinical outcome after rescue coronary angioplasty.
    Petronio AS, Musumeci G, Limbruno U, De Carlo M, Baglini R, Paterni G, Grazia Delle Donne M, Caravelli P, Nardi C, Mariani M.
    Am Heart J; 2002 Feb; 143(2):334-41. PubMed ID: 11835040
    [Abstract] [Full Text] [Related]

  • 6. Early abciximab administration before primary percutaneous coronary intervention improves infarct-related artery patency and left ventricular function in high-risk patients with anterior wall myocardial infarction: a randomized study.
    Rakowski T, Zalewski J, Legutko J, Bartus S, Rzeszutko L, Dziewierz A, Sorysz D, Bryniarski L, Zmudka K, Kaluza GL, Dubiel JS, Dudek D.
    Am Heart J; 2007 Mar; 153(3):360-5. PubMed ID: 17307412
    [Abstract] [Full Text] [Related]

  • 7. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
    Taglieri N, Saia F, Guiducci V, Tondi S, Conrotto F, Marrozzini C, Rocchi G, Biagini E, Reggiani ML, Giacometti P, Piovaccari G, Manari A, Marzocchi A, FATA Trial Investigators.
    Am J Cardiol; 2009 Mar 15; 103(6):785-90. PubMed ID: 19268732
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysis.
    Di Pasquale P, Cannizzaro S, Scalzo S, Maringhini G, Vitrano GM, Giubilato A, Giambanco F, Sarullo FM, Paterna S.
    Int J Cardiol; 2003 Dec 15; 92(2-3):265-70. PubMed ID: 14659863
    [Abstract] [Full Text] [Related]

  • 11. In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program.
    Hassan AK, Liem SS, van der Kley F, Bergheanu SC, Wolterbeek R, Bosch J, Bootsma M, Zeppenfeld K, van der Laarse A, Atsma DE, Jukema JW, Schalij MJ.
    Catheter Cardiovasc Interv; 2009 Aug 01; 74(2):335-43. PubMed ID: 19642182
    [Abstract] [Full Text] [Related]

  • 12. Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.
    Bajaj RR, Mohammad A, Hong T, Irfan A, Sharieff W, Bagnall A, Christie JA, Kutryk MJ, Chisholm RJ, Cheema AN.
    J Invasive Cardiol; 2010 Aug 01; 22(8):347-52. PubMed ID: 20679668
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Facilitated primary coronary intervention with abciximab and very low dose of alteplase during off-hours compared with direct primary intervention during regular hours.
    Maioli M, Gallopin M, Leoncini M, Bellandi F, Toso A, Dabizzi RP.
    Catheter Cardiovasc Interv; 2005 Aug 01; 65(4):484-91. PubMed ID: 15973688
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction.
    Costantini CO, Stone GW, Mehran R, Aymong E, Grines CL, Cox DA, Stuckey T, Turco M, Gersh BJ, Tcheng JE, Garcia E, Griffin JJ, Guagliumi G, Leon MB, Lansky AJ.
    J Am Coll Cardiol; 2004 Jul 21; 44(2):305-12. PubMed ID: 15261923
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pressure-derived fractional collateral blood flow: a primary determinant of left ventricular recovery after reperfused acute myocardial infarction.
    Lee CW, Park SW, Cho GY, Hong MK, Kim JJ, Kang DH, Song JK, Lee HJ, Park SJ.
    J Am Coll Cardiol; 2000 Mar 15; 35(4):949-55. PubMed ID: 10732893
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.